サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1717650

椎体間固定装置の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore

Interbody Fusion Device Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: ALIF Market, PLIF Market, and 4 more

出版日
ページ情報
英文 139 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
椎体間固定装置の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore
出版日: 2025年04月17日
発行: iData Research Inc.
ページ情報: 英文 139 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の椎体間固定装置の市場規模は、2024年に31億米ドル超となりました。同市場は4.3％のCAGRで拡大し、2031年には42億米ドルを超えると予測されています。

当レポートには、以下のセグメンテーションが含まれています：

  • 前方腰椎椎体間固定装置（ALIF）
  • 後方腰椎椎体間固定装置（PLIF）
  • 経鏡的腰椎椎体間固定装置（TLIF）
  • 頚椎椎体間固定装置（CIF）
  • VBR/椎体部分切除術
  • 拡張型椎体間デバイス

含まれる市場データ

  • 販売台数
  • 平均販売価格（ASP）
  • 市場規模および成長動向
  • 手術件数
  • 市場促進要因と抑制要因
  • 2031年までの市場予測
  • 2024年までの過去データ
  • 最近のM&A
  • 企業プロファイルと製品ポートフォリオ
  • 主要競合企業

世界の脊椎間固定装置市場動向

  • 脊椎固定装置市場における主な抑制要因は、低侵襲手術（MIS）椎体間デバイスの台頭です。
  • MIS技術は組織外傷を減らし、合併症発生率を下げ、手術時間を短縮します。
  • 良好な臨床結果が成熟市場での採用に拍車をかけ、新興市場にも同様の影響を与えると予想されます。
  • 開腹手術よりもMIS手術が好まれる傾向は、従来の胴体間固定装置の成長性に影響を与え続けています。

体幹部間固定装置の世界市場シェアの洞察

  • Medtronic
    • 2024年の市場リーダー。北米とアジア太平洋地域の一部で強い優位性を持っている。
    • 主要製品は以下の通り：
      • Elevate（TM）拡張型ケージ
      • アナトミック（R）PTCおよびコーナーストーン（R）PSR（頸椎セグメント）
      • Capstone（R）ケージ、Cornerstone L ASR（R）、その他の骨ダボ/ウェッジ
      • ARTiC（TM）ラインの3Dプリント金属デバイス
    • Medtronicは、VBRおよび拡張型椎体間セグメントでもリードしている。
  • DePuy Synthes
    • 2024年に世界第2位の競合。
    • CFRP（炭素繊維強化ポリマー）製腰椎椎体間ケージや様々な骨/非骨器具を提供。
    • 西欧とアジア太平洋での市場プレゼンスが高く、シェアに大きく貢献。
  • Globus Medical / NuVasive
    • 2023年合併後の主要競合。
    • 以下を通じて市場シェアを拡大すると予想される：
      • 世界規模の補完
      • 商業的リーチの拡大
      • 脊椎・整形外科領域における豊富な製品ポートフォリオ
      • 強力な外科医の関与と研究開発投資
    • 両社の強みを組み合わせることで、合併後の事業体は、椎体間の全サブセグメントにおいて継続的な成長を遂げることができます。

市場セグメンテーションサマリー

  • 前方腰椎椎体間固定装置（ALIF）
  • 後方腰椎椎体間固定装置（PLIF）
  • 経鏡的腰椎椎体間固定装置（TLIF）
  • 頸椎椎体間固定装置（CIF）
  • VBR/椎体部分切除術
  • 拡張型椎体間デバイス

調査範囲サマリー

  • 対象地域
    • 北米：カナダ、米国
    • ラテンアメリカ：アルゼンチン、ボリビア、ブラジル、チリ、コロンビア、コスタリカ、ドミニカ共和国、エクアドル、グアテマラ、メキシコ、パナマ、パラグアイ、ペルー、プエルトリコ、ウルグアイ、ベネズエラ
    • 西欧オーストリア、ベネルクス、フランス、ドイツ、イタリア、ポルトガル、スカンジナビア、スペイン、スイス、英国
    • 中欧・東欧：アゼルバイジャン、バルト三国、ベラルーシ、ブルガリア、クロアチア、チェコ共和国、グルジア、ギリシャ、ハンガリー、カザフスタン、ポーランド、ルーマニア、ロシア、セルビア、スロバキア、スロベニア、トルコ、ウクライナ
    • 中東バーレーン、イラン、イスラエル、クウェート、オマーン、カタール、サウジアラビア、アラブ首長国連邦
    • アジア太平洋：オーストラリア、カンボジア、中国、香港、インド、インドネシア、日本、キルギス、マカオ、マレーシア、モンゴル、ミャンマー、ニュージーランド、パキスタン、フィリピン、シンガポール、韓国、スリランカ、台湾、タイ、ウズベキスタン、ベトナム
    • アフリカ：アルジェリア、エジプト、エチオピア、ガーナ、ケニア、リビア、モロッコ、ナイジェリア、南アフリカ、スーダン、ウガンダ
  • 基準年：2024年
  • 予測期間：2025年～2031年
  • 過去データ：2021年～2023年

定量データ

  • 手術件数
  • 市場規模
  • 市場シェア
  • 市場予測
  • 市場成長率
  • 販売台数
  • 平均販売価格

定性的データ

  • 市場成長動向
  • 市場抑制要因
  • 競合分析およびトップ企業のSWOT
  • 合併と買収
  • 企業プロファイル
  • 製品ポートフォリオ
  • FDAリコール
  • 破壊的技術
  • 疾患概要

データソース

  • 業界リーダーへの一次インタビュー
  • 政府医師データ
  • 規制データ
  • 病院データ
  • 輸出入データ
  • 社内データベース

当レポートでは、世界の椎体間固定装置市場について調査し、市場の概要とともに、市場分析と予測、促進要因と抑制要因、競合情勢などを提供しています。

目次

椎体間固定装置市場

エグゼクティブサマリー

  • 世界の椎体間固定装置市場概要
  • 競合分析
  • 市場セグメンテーション
  • 対象地域

イントロダクション

  • ALIF
  • PLIF
  • TLIF
  • CIF
  • VBR/椎体部分切除術

手技件数

  • 全椎体間固定装置
  • ALIF手技
  • PLIF手技
  • TLIF手技
  • CIF手技
  • VBR/椎椎体部分切除術による椎体間デバイス手術
  • 拡張型椎体間デバイス手術

市場概要

  • セグメント別
  • 地域別

市場分析と予測

  • 椎体間固定装置市場全体
  • ALIF市場
  • PLIF市場
  • TLIF市場
  • CIF市場
  • VBR/体切除椎体間デバイス市場
  • 拡張型椎間デバイス市場

促進要因と抑制要因

競合市場シェア分析

図表

LIST OF CHARTS

  • Chart 7-1: Interbody Fusion Market, Global, 2024 & 2031
  • Chart 7-2: Interbody Fusion Procedures, Global, 2024
  • Chart 7-3: Interbody Fusion Procedures by Region, Global, 2021 - 2031
  • Chart 7-4: Interbody Fusion Device Market by Segment, Global, 2021 - 2031
  • Chart 7-5: Interbody Fusion Device Market by Region, Global, 2021 - 2031
  • Chart 7-6: Leading Competitors, Interbody Fusion Market, Global, 2024

LIST OF FIGURES

  • Figure 7-1: Interbody Fusion Procedure Segmentation
  • Figure 7-2: Interbody Fusion Market Segmentation
  • Figure 7-3: Interbody Fusion Regions Covered, Global (1 of 2)
  • Figure 7-4: Interbody Fusion Regions Covered, Global (2 of 2)
  • Figure 7-5: Interbody Fusion Procedures by Segment, Global, 2021 - 2031
  • Figure 7-6: Interbody Fusion Procedures by Region, Global, 2021 - 2031
  • Figure 7-7: Interbody Fusion Procedures by Country, North America, 2021 - 2031
  • Figure 7-8: Interbody Fusion Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-9: Interbody Fusion Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-10: Interbody Fusion Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-11: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-12: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-13: Interbody Fusion Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-14: Interbody Fusion Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-15: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-16: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-17: Interbody Fusion Procedures by Country, Africa, 2021 - 2031
  • Figure 7-18: ALIF Procedures by Region, Global, 2021 - 2031
  • Figure 7-19: ALIF Procedures by Country, North America, 2021 - 2031
  • Figure 7-20: ALIF Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-21: Deformity Correction Thoracolumbar Fixation Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-22: ALIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-23: ALIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-24: ALIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-25: ALIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-26: ALIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-27: ALIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-28: ALIF Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-29: ALIF Procedures by Country, Africa, 2021 - 2031
  • Figure 7-30: PLIF Procedures by Region, Global, 2021 - 2031
  • Figure 7-31: PLIF Procedures by Country, North America, 2021 - 2031
  • Figure 7-32: PLIF Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-33: PLIF Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-34: PLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-35: PLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-36: PLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-37: PLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-38: PLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-39: PLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-40: PLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-41: PLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 7-42: TLIF Procedures by Region, Global, 2021 - 2031
  • Figure 7-43: TLIF Procedures by Country, North America, 2021 - 2031
  • Figure 7-44: TLIF Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-45: TLIF Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-46: TLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-47: TLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-48: TLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-49: TLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-50: TLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-51: TLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-52: TLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-53: TLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 7-54: CIF Procedures by Region, Global, 2021 - 2031
  • Figure 7-55: CIF Procedures by Country, North America, 2021 - 2031
  • Figure 7-56: CIF Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-57: CIF Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-58: CIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-59: CIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-60: CIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-61: CIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-62: CIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-63: CIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-64: CIF Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-65: CIF Procedures by Country, Africa, 2021 - 2031
  • Figure 7-66: VBR/Corpectomy Procedures by Region, Global, 2021 - 2031
  • Figure 7-67: VBR/Corpectomy Procedures by Country, North America, 2021 - 2031
  • Figure 7-68: VBR/Corpectomy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-69: VBR/Corpectomy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-70: VBR/Corpectomy Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-71: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-72: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-73: VBR/Corpectomy Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-74: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-75: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-76: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-77: VBR/Corpectomy Procedures by Country, Africa, 2021 - 2031
  • Figure 7-78: Expandable Procedures by Region, Global, 2021 - 2031
  • Figure 7-79: Expandable Procedures by Country, North America, 2021 - 2031
  • Figure 7-80: Expandable Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-81: Expandable Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-82: Expandable Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-83: Expandable Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-84: Expandable Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-85: Expandable Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-86: Expandable Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-87: Expandable Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-88: Expandable Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-89: Expandable Procedures by Country, Africa, 2021 - 2031
  • Figure 7-90: Interbody Fusion Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 7-91: Interbody Fusion Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 7-92: Interbody Fusion Market, Global, 2021 - 2031
  • Figure 7-93: Units Sold by Region, Interbody Fusion Market, Global, 2021 - 2031
  • Figure 7-94: Average Selling Price by Region, Interbody Fusion Market, Global, 2021 - 2031 (US$)
  • Figure 7-95: Market Value by Region, Interbody Fusion Market, Global, 2021 - 2031 (US$M)
  • Figure 7-96: ALIF Market, Global, 2021 - 2031
  • Figure 7-97: Units Sold by Region, ALIF Market, Global, 2021 - 2031
  • Figure 7-98: Average Selling Price by Region, ALIF Market, Global, 2021 - 2031 (US$)
  • Figure 7-99: Market Value by Region, ALIF Market, Global, 2021 - 2031 (US$M)
  • Figure 7-100: PLIF Market, Global, 2021 - 2031
  • Figure 7-101: Units Sold by Region, PLIF Market, Global, 2021 - 2031
  • Figure 7-102: Average Selling Price by Region, PLIF Market, Global, 2021 - 2031 (US$)
  • Figure 7-103: Market Value by Region, PLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 7-104: TLIF Market, Global, 2021 - 2031
  • Figure 7-105: Units Sold by Region, TLIF Market, Global, 2021 - 2031
  • Figure 7-106: Average Selling Price by Region, TLIF Market, Global, 2021 - 2031 (US$)
  • Figure 7-107: Market Value by Region, TLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 7-108: CIF Market, Global, 2021 - 2031
  • Figure 7-109: Units Sold by Region, CIF Market, Global, 2021 - 2031
  • Figure 7-110: Average Selling Price by Region, CIF Market, Global, 2021 - 2031 (US$)
  • Figure 7-111: Market Value by Region, CIF Market, Global, 2021 - 2031 (US$M)
  • Figure 7-112: VBR/Corpectomy Interbody Device Market, Global, 2021 - 2031
  • Figure 7-113: Units Sold by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 - 2031
  • Figure 7-114: Average Selling Price by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 - 2031 (US$)
  • Figure 7-115: Market Value by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 - 2031 (US$M)
  • Figure 7-116: Expandable Interbody Device Market, Global, 2021 - 2031
  • Figure 7-117: Units Sold by Region, Expandable Interbody Device Market, Global, 2021 - 2031
  • Figure 7-118: Average Selling Price by Region, Expandable Interbody Device Market, Global, 2021 - 2031 (US$)
  • Figure 7-119: Market Value by Region, Expandable Interbody Device Market, Global, 2021 - 2031 (US$M)
  • Figure 7-120: Leading Competitors, Interbody Fusion Market, Global, 2024
目次
Product Code: iDATA_GLSP25_MC_IF

The global interbody fusion market was valued at over $3.1 billion in 2024.

It is projected to grow at a CAGR of 4.3% to surpass $4.2 billion by 2031.

The full report suite includes segmentation for:

  • Anterior Lumbar Interbody Fusion (ALIF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)
  • Cervical Interbody Fusion (CIF)
  • VBR/Corpectomy
  • Expandable Interbody Devices

Market Data Included

  • Unit Sales
  • Average Selling Prices (ASPs)
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Historical Data to 2024
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

Global Interbody Fusion Device Market Trends

  • The primary limiter in the spinal fusion market is the rise of minimally invasive surgical (MIS) interbody devices.
  • MIS techniques reduce tissue trauma, lower complication rates, and shorten surgery duration.
  • Positive clinical outcomes have fueled adoption in mature markets and are expected to similarly affect emerging markets.
  • Preference for MIS over open techniques continues to impact growth potential of traditional interbody devices.

Global Interbody Fusion Device Market Share Insights

  • 1 Medtronic
    • Market leader in 2024, with strong dominance in North America and parts of Asia-Pacific.
    • Key products include:
      • Elevate(TM) expandable cage
      • Anatomic(R) PTC and Cornerstone(R) PSR (cervical segment)
      • Capstone(R) cage, Cornerstone L ASR(R), and other bone dowels/wedges
      • ARTiC(TM) line of 3D-printed metal devices
    • Medtronic also leads in VBR and expandable interbody segments.
  • 2 DePuy Synthes
    • Second-largest global competitor in 2024.
    • Offers CFRP (carbon fiber reinforced polymer) lumbar interbody cages and various bone/non-bone devices.
    • Strong market presence in Western Europe and Asia-Pacific contributes significantly to its share.
  • 3 Globus Medical / NuVasive
    • Major competitor post-2023 merger.
    • Anticipated to gain market share through:
      • Complementary global scale
      • Expanded commercial reach
      • Extensive product portfolio in spine and orthopedics
      • Strong surgeon engagement and R&D investment
    • Combined strengths position the merged entity for continued growth across all interbody subsegments.

Market Segmentation Summary

  • Anterior Lumbar Interbody Fusion (ALIF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)
  • Cervical Interbody Fusion (CIF)
  • VBR/Corpectomy Devices
  • Expandable Interbody Devices

Research Scope Summary

  • Regions Covered
    • North America: Canada, United States
    • Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
    • Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
    • Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
    • Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
    • Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
    • Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Data

  • Procedure Numbers
  • Market Size
  • Market Shares
  • Market Forecasts
  • Market Growth Rates
  • Units Sold
  • Average Selling Prices

Qualitative Data

  • Market Growth Trends
  • Market Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles
  • Product Portfolios
  • FDA Recalls
  • Disruptive Technologies
  • Disease Overviews

Data Sources

  • Primary Interviews with Industry Leaders
  • Government Physician Data
  • Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

Interbody Fusion Market

  • 7.1 Executive Summary
    • 7.1.1 Global Interbody Fusion Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Procedure Segmentation
    • 7.1.4 Market Segmentation
    • 7.1.5 Regions Included
  • 7.2 Introduction
    • 7.2.1 ALIF
    • 7.2.2 PLIF
    • 7.2.3 TLIF
    • 7.2.4 CIF
    • 7.2.5 VBR/Corpectomy
  • 7.3 Procedure Numbers
    • 7.3.1 Total Interbody Fusion Procedures
    • 7.3.2 ALIF Procedures
    • 7.3.3 PLIF Procedures
    • 7.3.4 TLIF Procedures
    • 7.3.5 CIF Procedures
    • 7.3.6 VBR/Corpectomy Interbody Device Procedures
    • 7.3.7 Expandable Interbody Device Procedures
  • 7.4 Market Overview
    • 7.4.1 By Segment
    • 7.4.2 By Region
  • 7.5 Market Analysis and Forecast
    • 7.5.1 Total Interbody Fusion Market
    • 7.5.2 ALIF Market
    • 7.5.3 PLIF Market
    • 7.5.4 TLIF Market
    • 7.5.5 CIF Market
    • 7.5.6 VBR/Corpectomy Interbody Device Market
    • 7.5.7 Expandable Interbody Device Market
  • 7.6 Drivers and Limiters
    • 7.6.1 Market Drivers
    • 7.6.2 Market Limiters
  • 7.7 Competitive Market Share Analysis